Sfoglia per AUTORE
RICHETTA AG
Collezione AOU Novara

  

Items : 3

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2025 Mar;39 Suppl 1:7-14. doi: 10.1111/jdv.20187. Epub 2024 Jun 26.
2025
AOU Novara

Bonifati C; Lembo S; Richetta AG; Romanelli M; Satolli F; Corazza M; Atzori L; Lasagni C; Potenza C; Savoia P; Bardazzi F; Di Lernia VG; Bianchi L; Fabbrocini G; Giofrè C; Zichichi L; Guarneri C; Pallotta S; Fargnoli MC; Loconsole F; Offidani A; Burlando M; Piaserico S; Peris K; Papini M; Carrera CG; Costanzo A; Prignano F; Bongiorno MR; et alii...

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2021 Feb;21(2):271-277. doi: 10.1080/14712598.2021.1853698. Epub 2021 Jan 13.
2021
AOU Novara

Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; et alii...

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. in Patient preference and adherence / Patient Prefer Adherence. 2021 Nov 19;15:2551-2562. doi: 10.2147/PPA.S326498. eCollection 2021.
2021
ASL Alessandria
ASL Torino 4
AOU Novara

Uzzauto MT; Travaglini M; Tiberio R; Richetta AG; Savoia P; Peris K; Malara G; Loconsole F; Leporati C; Lembo S; Giofrè C; Foti C; De Pasquale R; Fargnoli MC; Coppola S; Costanzo A; Castelli G; Baggini G; Baldari M; Aragone MG; Amerio P; Argenziano G; Bianchi L;